BlackRock Investment Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $4.61M | Sell |
142,579
-7,224
| -5% | -$233K | 0.01% | 1638 |
|
2016
Q3 | $5.13M | Buy |
149,803
+14,348
| +11% | +$491K | 0.01% | 1463 |
|
2016
Q2 | $4.57M | Buy |
135,455
+9,206
| +7% | +$311K | 0.01% | 1496 |
|
2016
Q1 | $6.69M | Buy |
126,249
+3,612
| +3% | +$191K | 0.01% | 1181 |
|
2015
Q4 | $9.42M | Buy |
122,637
+135
| +0.1% | +$10.4K | 0.01% | 968 |
|
2015
Q3 | $5.04M | Sell |
122,502
-1,224
| -1% | -$50.3K | 0.01% | 1370 |
|
2015
Q2 | $8.75M | Buy |
123,726
+25,338
| +26% | +$1.79M | 0.01% | 1088 |
|
2015
Q1 | $8.74M | Buy |
98,388
+1,428
| +1% | +$127K | 0.01% | 1025 |
|
2014
Q4 | $8.6M | Sell |
96,960
-4,016
| -4% | -$356K | 0.01% | 1033 |
|
2014
Q3 | $9.79M | Buy |
100,976
+3,569
| +4% | +$346K | 0.01% | 923 |
|
2014
Q2 | $8.95M | Buy |
97,407
+21,347
| +28% | +$1.96M | 0.01% | 1036 |
|
2014
Q1 | $5.32M | Buy |
76,060
+327
| +0.4% | +$22.9K | 0.01% | 1316 |
|
2013
Q4 | $4.35M | Sell |
75,733
-1,969
| -3% | -$113K | 0.01% | 1432 |
|
2013
Q3 | $3.74M | Buy |
77,702
+4,937
| +7% | +$237K | 0.01% | 1473 |
|
2013
Q2 | $2.11M | Buy |
+72,765
| New | +$2.11M | ﹤0.01% | 1813 |
|